Gokhale R S, Agarwalla S, Santi D V, Balaram P
Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
Biochemistry. 1996 Jun 4;35(22):7150-8. doi: 10.1021/bi952890e.
Urea and guanidinium chloride induced unfolding of thymidylate synthase, a dimeric enzyme, and engineered interface mutants have been monitored by circular dichroism, fluorescence, and size-exclusion chromatography. Equilibrium unfolding studies show biphasic transitions, with a plateau between 3.5 and 5 M urea, when monitored by far-UV CD and fluorescence energy transfer employing an (aminoethylamino) naphthalenesulfonyl (AEDANS) label at the active site residue, Cys198. AEDANS was also specifically incorporated at position Cys155 in the mutant protein T155C. Direct excitation of this extrinsic fluorophore in the wild type protein (labeled at Cys198) and mutant T155C (labeled at Cys155) showed remarkable differences in the unfolding profiles. C155 AEDANS has a transition centered at 3.5 M urea, which is in contrast to Cys 198 AEDANS (5.5 M urea). Unfolding studies monitored by following intrinsic fluorescence of Trp residues which are located in a small structural domain suggest that this region of the protein is intrinsically fragile. The stable equilibrium intermediate is identified to be an ensemble of partially unfolded aggregated species by gel filtration studies. The chaotrope-induced denaturation of TS appears to proceed through a partially unfolded intermediate that is stabilized by aggregation. Dissociation and loss of structure occur concomitantly at high denaturant concentrations. Introduction of two symmetrically positioned disulfide bridges across the dimer interface in the triple mutant T155C/E188C/C244T (TSMox) stabilized the protein against denaturant-induced unfolding. Aggregate formation was completely abolished in the mutant TSMox, which also enhanced the overall structural stability of the protein. Structural reinforcement of the fragile interface in thymidylate synthase results in dramatic stabilization toward chaotrope-induced unfolding.
已通过圆二色性、荧光和尺寸排阻色谱法监测了尿素和氯化胍诱导的二聚体酶胸苷酸合成酶及其工程化界面突变体的去折叠过程。平衡去折叠研究显示,当通过远紫外圆二色性和使用位于活性位点残基Cys198处的(氨基乙基氨基)萘磺酰基(AEDANS)标记进行荧光能量转移监测时,呈现双相转变,在3.5至5 M尿素之间有一个平台期。AEDANS也被特异性地掺入突变蛋白T155C的Cys155位置。在野生型蛋白(标记于Cys198)和突变体T155C(标记于Cys155)中对这种外在荧光团的直接激发显示,去折叠谱有显著差异。C155 AEDANS的转变中心在3.5 M尿素处,这与Cys 198 AEDANS(5.5 M尿素)形成对比。通过追踪位于一个小结构域中的色氨酸残基的固有荧光进行的去折叠研究表明,该蛋白的这一区域本质上是脆弱的。通过凝胶过滤研究确定稳定的平衡中间体是部分去折叠的聚集物种的集合。促溶剂诱导的胸苷酸合成酶变性似乎通过一个由聚集稳定的部分去折叠中间体进行。在高变性剂浓度下,解离和结构丧失同时发生。在三重突变体T155C/E188C/C244T(TSMox)中,在二聚体界面引入两个对称定位的二硫键,使蛋白对变性剂诱导的去折叠具有抗性。在突变体TSMox中完全消除了聚集体形成,这也增强了蛋白的整体结构稳定性。胸苷酸合成酶中脆弱界面的结构强化导致对促溶剂诱导的去折叠有显著的稳定性。